Domestic and International Exchange Dynamics-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Professor Xu Yi from Yinfeng Cryomedicine Expert Committee Elected as Board Governor of International Society of Cryobiology

Future Promise Salon Event Successfully Held: Yinfeng Life Extension Plan Members Engage in a Warm Dialogue on Life and the Future

"10th China Contemporary Thanatology Symposium in Macao: Yinfeng Promotes Life Education Through Technology"

The World’s First Ovarian Tissue Dual-Activation Technology Selected into the 2025 "Shandong Outstanding Achievements Report" Project

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

Professor Xu Yi from Yinfeng Cryomedicine Expert Committee Elected as Board Governor of International Society of Cryobiology

2025/12/19

According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.

Future Promise Salon Event Successfully Held: Yinfeng Life Extension Plan Members Engage in a Warm Dialogue on Life and the Future

2025/12/09

The significance of life extension lies not only in technological breakthroughs but also in the shared belief of every individual who believes in "a better future." With faith as their torch, these fellow travelers join hands, pooling their strength to stride forward together. We firmly believe that as this steadfast support converges into a powerful force, it will propel the Yinfeng Life Extension Plan to gain broader attention, inject continuous momentum into the development of cryobiomedicine, and illuminate the next chapter of human civilization.

"10th China Contemporary Thanatology Symposium in Macao: Yinfeng Promotes Life Education Through Technology"

2025/10/14

Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.

The World’s First Ovarian Tissue Dual-Activation Technology Selected into the 2025 "Shandong Outstanding Achievements Report" Project

2025/10/13

According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).

2016-08-29

→

Ben Best, former president of the American Institute of Human Cryology (CI), visited and exchanged ideas

On the afternoon of August 29, 2016, Ben Best, former president of the American Institute of Human Crystalsis (CI), and Jeremy Yan, president of the Asian Human Crystalsis Company, arrived at the Yinfeng Life Science Foundation in Shandong Province. The two sides had in-depth exchanges on the life extension research program funded by the foundation.

2015-07-19

→

The preparatory group of the foundation inspected the American Institute of Human Cryology CI and Alcor Life Extension Charity Foundation

In July 2015, the preparatory team of the foundation went to the United States to investigate the Institute of Human Cryology (CI). Conduct in-depth exchanges and sign a memorandum of cooperation on human low-temperature preservation research.

2015-06-29

→

Mr. Jose, an expert from Alcor Life Extension Foundation in the United States, visited our hospital for investigation

In June 2015, Mr. Jose from Alcor Life Extension Foundation in the United States visited Yinfeng Biotechnology for investigation. Professor Shen Bojun, Chief Scientist of Yinfeng Biology, Professor Qu Tingyu, Aaron Drake, and others accompanied the reception and exchange.

2014-04-19

→

Exchange and cooperation between the preparatory group of the foundation and KrioRus, Russia

In order to strengthen contact and cooperation with international low-temperature medical research institutions, in April 2014, the preparatory group of the foundation visited KrioRus, Russia for inspection and signed a memorandum of cooperation. In October and November of the same year, Russian KrioRus low-temperature freezing experts Udlova and Daniela Medvedev visited China for exchange and visits. By conducting research and exchange with KrioRus from Russia, it provides reference and guidance for the development of life continuity research programs.